Aug 21, 2026 20:05 UTC research Lead thesis receipt {"chart_pattern": "Pattern pending", "company": "10x Genomics, Inc.", "decision": "keep_in_lead_intake", "decision_reason": "Iris kept in lead intake after immediate research. Score 65. Still needs: verified catalyst.", "narrative": "TXG: research only. No default size. Kevin-style research chain: 1. Lead source: TXG entered from full_market_scan; measured setup evidence initiated review. 2. Volume / attention: relative volume 1.0174 3. Catalyst / story: No verified catalyst recorded; the measured technical setup is the current reason for attention. 4. Comp / narrative analogy: No verified comparable-company framing recorded. 5. Chart / support line: Pattern Pattern pending; price 65.12; trigger 65.54; stop/support 57.41; risk 12.4%. 5b. Measured setup validation: status not validated validated pattern none base duration not validly supplied base depth not validly supplied range contraction not validly supplied pivot rejection 0.535% defects recorded: 1 6. O\u2019Neil / quality gate: CANSLIM D / 44.76; missing C, A, N, I, M. 7. Verification gaps: verified catalyst 8. Thesis alive/dead: Confirms: Breakout through trigger on expanding volume. Kills: Loss of recent structure / stop invalidation. CANSLIM/O\u2019Neil read: D / 44.76. Missing letters: C, A, N, I, M. Chart read: Pattern pending (low confidence). Trigger 65.54 Stop/invalidation 57.41. Current stance: kept in lead intake. Iris is not treating this as investable until confirmation is met and A) Execution submits/records an official working order.", "price": 65.12, "setup": "Volatility Contraction", "status": "Lead intake", "stop": 57.41, "trigger": 65.54, "what_confirms": "Breakout through trigger on expanding volume", "what_kills": "Loss of recent structure / stop invalidation", "why_now": "Measured setup and leadership evidence qualified this candidate for research."}
Aug 21, 2026 20:05 UTC research Research funnel context raw_input — Intake retained as raw input; researched classification requires primary-source receipt.
Aug 21, 2026 20:05 UTC research Research cron update Decision: keep_in_lead_intake at score 65.0; setup Volatility Contraction; trigger 65.54 / stop 57.41. Kevin Xu lens: volume 1.0174; catalyst/story Full-market query hit: leadership base, sector relative strength; support/risk line defined. Kevin-style verbose research: 1. Lead source: TXG entered from full_market_scan; measured setup evidence initiated review. 2. Volume / attention: relative volume 1.0174 3. Catalyst / story: No verified catalyst recorded; the measured technical setup is the current reason for attention. 4. Comp / narrative analogy: No verified comparable-company framing recorded. 5. Chart / support line: Pattern Pattern pending; price 65.12; trigger 65.54; stop/support 57.41; risk 12.4%. 5b. Measured setup validation: status not validated validated pattern none base duration not validly supplied base depth not validly supplied range contraction not validly supplied pivot rejection 0.535% defects recorded: 1 6. O’Neil / quality gate: CANSLIM D / 44.76; missing C, A, N, I, M. 7. Verification gaps: verified catalyst 8. Thesis alive/dead: Confirms: Breakout through trigger on expanding volume. Kills: Loss of recent structure / stop invalidation. Qullamaggie lens: Pattern pending; confirmation requires price/volume continuation, not stale list repetition. O’Neil lens: CANSLIM D / 44.76; gate 🟡 Technical setup, fundamentals incomplete; pivot 65.54; sell rule 57.41. No new blocking research gaps from this pass.
Aug 21, 2026 14:00 UTC history Historical thesis receipt {"chart_pattern": "Pattern pending", "company": "10x Genomics, Inc.", "decision": "keep_in_lead_intake", "decision_reason": "Iris kept in lead intake after immediate research. Score 65. Still needs: verified catalyst.", "narrative": "TXG: research only. No default size. Kevin-style research chain: 1. Lead source: TXG entered from full_market_scan; measured setup evidence initiated review. 2. Volume / attention: relative volume 0.0954 3. Catalyst / story: No verified catalyst recorded; the measured technical setup is the current reason for attention. 4. Comp / narrative analogy: No verified comparable-company framing recorded. 5. Chart / support line: Pattern Pattern pending; price 62.68; trigger 64.66; stop/support 56.66; risk 12.37%. 5b. Measured setup validation: status not validated validated pattern none base duration not validly supplied base depth not validly supplied range contraction not validly supplied pivot rejection 2.972% defects recorded: 1 6. O\u2019Neil / quality gate: CANSLIM D / 41.9; missing C, A, N, I, M. 7. Verification gaps: verified catalyst 8. Thesis alive/dead: Confirms: Breakout through trigger on expanding volume. Kills: Loss of recent structure / stop invalidation. CANSLIM/O\u2019Neil read: D / 41.9. Missing letters: C, A, N, I, M. Chart read: Pattern pending (low confidence). Trigger 64.66 Stop/invalidation 56.66. Current stance: kept in lead intake. Iris is not treating this as investable until confirmation is met and A) Execution submits/records an official working order.", "price": 62.68, "setup": "Volatility Contraction", "status": "Lead intake", "stop": 56.66, "trigger": 64.66, "what_confirms": "Breakout through trigger on expanding volume", "what_kills": "Loss of recent structure / stop invalidation", "why_now": "Measured setup and leadership evidence qualified this candidate for research."}
Aug 21, 2026 14:00 UTC research Research cron update Decision: keep_in_lead_intake at score 65.0; setup Volatility Contraction; trigger 64.66 / stop 56.66. Kevin Xu lens: volume 0.0954; catalyst/story Full-market query hit: leadership base, sector relative strength; support/risk line defined. Kevin-style verbose research: 1. Lead source: TXG entered from full_market_scan; measured setup evidence initiated review. 2. Volume / attention: relative volume 0.0954 3. Catalyst / story: No verified catalyst recorded; the measured technical setup is the current reason for attention. 4. Comp / narrative analogy: No verified comparable-company framing recorded. 5. Chart / support line: Pattern Pattern pending; price 62.68; trigger 64.66; stop/support 56.66; risk 12.37%. 5b. Measured setup validation: status not validated validated pattern none base duration not validly supplied base depth not validly supplied range contraction not validly supplied pivot rejection 2.972% defects recorded: 1 6. O’Neil / quality gate: CANSLIM D / 41.9; missing C, A, N, I, M. 7. Verification gaps: verified catalyst 8. Thesis alive/dead: Confirms: Breakout through trigger on expanding volume. Kills: Loss of recent structure / stop invalidation. Qullamaggie lens: Pattern pending; confirmation requires price/volume continuation, not stale list repetition. O’Neil lens: CANSLIM D / 41.9; gate 🟡 Technical setup, fundamentals incomplete; pivot 64.66; sell rule 56.66. No new blocking research gaps from this pass.
Aug 20, 2026 14:00 UTC history Historical thesis receipt {"chart_pattern": "Pattern pending", "company": "10x Genomics, Inc.", "decision": "keep_in_lead_intake", "decision_reason": "Iris kept in lead intake after immediate research. Score 65. Still needs: verified catalyst.", "narrative": "TXG: research only. No default size. Kevin-style research chain: 1. Lead source: TXG entered from full_market_scan; measured setup evidence initiated review. 2. Volume / attention: relative volume 0.0944 3. Catalyst / story: No verified catalyst recorded; the measured technical setup is the current reason for attention. 4. Comp / narrative analogy: No verified comparable-company framing recorded. 5. Chart / support line: Pattern Pattern pending; price 62.62; trigger 64.3; stop/support 56.33; risk 12.4%. 5b. Measured setup validation: status not validated validated pattern none base duration 28 sessions base depth 34.729% range contraction not validly supplied pivot rejection 2.522% defects recorded: 1 6. O\u2019Neil / quality gate: CANSLIM D / 41.9; missing C, A, N, I, M. 7. Verification gaps: verified catalyst 8. Thesis alive/dead: Confirms: Breakout through trigger on expanding volume. Kills: Loss of recent structure / stop invalidation. CANSLIM/O\u2019Neil read: D / 41.9. Missing letters: C, A, N, I, M. Chart read: Pattern pending (low confidence). Trigger 64.3 Stop/invalidation 56.33. Current stance: kept in lead intake. Iris is not treating this as investable until confirmation is met and A) Execution submits/records an official working order.", "price": 62.62, "setup": "Volatility Contraction", "status": "Lead intake", "stop": 56.33, "trigger": 64.3, "what_confirms": "Breakout through trigger on expanding volume", "what_kills": "Loss of recent structure / stop invalidation", "why_now": "Measured setup and leadership evidence qualified this candidate for research."}
Aug 20, 2026 14:00 UTC research Research cron update Decision: keep_in_lead_intake at score 65.0; setup Volatility Contraction; trigger 64.3 / stop 56.33. Kevin Xu lens: volume 0.0944; catalyst/story Full-market query hit: leadership base, sector relative strength; support/risk line defined. Kevin-style verbose research: 1. Lead source: TXG entered from full_market_scan; measured setup evidence initiated review. 2. Volume / attention: relative volume 0.0944 3. Catalyst / story: No verified catalyst recorded; the measured technical setup is the current reason for attention. 4. Comp / narrative analogy: No verified comparable-company framing recorded. 5. Chart / support line: Pattern Pattern pending; price 62.62; trigger 64.3; stop/support 56.33; risk 12.4%. 5b. Measured setup validation: status not validated validated pattern none base duration 28 sessions base depth 34.729% range contraction not validly supplied pivot rejection 2.522% defects recorded: 1 6. O’Neil / quality gate: CANSLIM D / 41.9; missing C, A, N, I, M. 7. Verification gaps: verified catalyst 8. Thesis alive/dead: Confirms: Breakout through trigger on expanding volume. Kills: Loss of recent structure / stop invalidation. Qullamaggie lens: Pattern pending; confirmation requires price/volume continuation, not stale list repetition. O’Neil lens: CANSLIM D / 41.9; gate 🟡 Technical setup, fundamentals incomplete; pivot 64.3; sell rule 56.33. No new blocking research gaps from this pass.
Aug 20, 2026 12:50 UTC history Historical thesis receipt {"chart_pattern": "Episodic pivot", "company": "10x Genomics, Inc.", "decision": "keep_in_lead_intake", "decision_reason": "Iris kept in lead intake after immediate research. Score 72. Still needs: validated Qullamaggie setup structure.", "narrative": "TXG: research only. No default size. Kevin-style research chain: 1. Lead source: TXG entered from full_market_scan; measured setup evidence initiated review. 2. Volume / attention: relative volume 1.2946 3. Catalyst / story: No verified catalyst recorded; the measured technical setup is the current reason for attention. 4. Comp / narrative analogy: No verified comparable-company framing recorded. 5. Chart / support line: Pattern Episodic pivot; price 62.19; trigger 62.42; stop/support 55.25; risk 11.49%. 5b. Measured setup validation: status not validated validated pattern none base duration 29 sessions base depth 33.547% range contraction not validly supplied pivot rejection 0.273% defects recorded: 1 6. O\u2019Neil / quality gate: CANSLIM D / 44.76; missing C, A, N, I, M. 7. Verification gaps: validated Qullamaggie setup structure 8. Thesis alive/dead: Confirms: Breakout through trigger on expanding volume. Kills: Loss of recent structure / stop invalidation. CANSLIM/O\u2019Neil read: D / 44.76. Missing letters: C, A, N, I, M. Chart read: Episodic pivot (watch confidence). Trigger 62.42 Stop/invalidation 55.25. Current stance: kept in lead intake. Iris is not treating this as investable until confirmation is met and A) Execution submits/records an official working order.", "price": 62.19, "setup": "Qullamaggie Episodic Pivot", "status": "Lead intake", "stop": 55.25, "trigger": 62.42, "what_confirms": "Breakout through trigger on expanding volume", "what_kills": "Loss of recent structure / stop invalidation", "why_now": "Measured setup and leadership evidence qualified this candidate for research."}
Aug 20, 2026 12:50 UTC research Research cron update Decision: keep_in_lead_intake at score 72.0; setup Qullamaggie Episodic Pivot; trigger 62.42 / stop 55.25. Kevin Xu lens: volume 1.2946; catalyst/story Full-market query hit: leadership base, momentum flag, episodic pivot, sector relative strength; support/risk line defined. Kevin-style verbose research: 1. Lead source: TXG entered from full_market_scan; measured setup evidence initiated review. 2. Volume / attention: relative volume 1.2946 3. Catalyst / story: No verified catalyst recorded; the measured technical setup is the current reason for attention. 4. Comp / narrative analogy: No verified comparable-company framing recorded. 5. Chart / support line: Pattern Episodic pivot; price 62.19; trigger 62.42; stop/support 55.25; risk 11.49%. 5b. Measured setup validation: status not validated validated pattern none base duration 29 sessions base depth 33.547% range contraction not validly supplied pivot rejection 0.273% defects recorded: 1 6. O’Neil / quality gate: CANSLIM D / 44.76; missing C, A, N, I, M. 7. Verification gaps: validated Qullamaggie setup structure 8. Thesis alive/dead: Confirms: Breakout through trigger on expanding volume. Kills: Loss of recent structure / stop invalidation. Qullamaggie lens: Episodic pivot; confirmation requires price/volume continuation, not stale list repetition. O’Neil lens: CANSLIM D / 44.76; gate 🟡 Technical setup, fundamentals incomplete; pivot 62.42; sell rule 55.25. Still needs: validated Qullamaggie setup structure.
Aug 19, 2026 20:05 UTC history Historical thesis receipt {"chart_pattern": "Episodic pivot", "company": "10x Genomics, Inc.", "decision": "keep_in_lead_intake", "decision_reason": "Iris kept in lead intake after immediate research. Score 72. Still needs: validated Qullamaggie setup structure.", "narrative": "TXG: research only. No default size. Kevin-style research chain: 1. Lead source: TXG entered from full_market_scan; measured setup evidence initiated review. 2. Volume / attention: relative volume 1.2813 3. Catalyst / story: No verified catalyst recorded; the measured technical setup is the current reason for attention. 4. Comp / narrative analogy: No verified comparable-company framing recorded. 5. Chart / support line: Pattern Episodic pivot; price 62.19; trigger 62.42; stop/support 55.25; risk 11.49%. 5b. Measured setup validation: status not validated validated pattern none base duration 29 sessions base depth 33.547% range contraction not validly supplied pivot rejection 0.273% defects recorded: 1 6. O\u2019Neil / quality gate: CANSLIM D / 44.76; missing C, A, N, I, M. 7. Verification gaps: validated Qullamaggie setup structure 8. Thesis alive/dead: Confirms: Breakout through trigger on expanding volume. Kills: Loss of recent structure / stop invalidation. CANSLIM/O\u2019Neil read: D / 44.76. Missing letters: C, A, N, I, M. Chart read: Episodic pivot (watch confidence). Trigger 62.42 Stop/invalidation 55.25. Current stance: kept in lead intake. Iris is not treating this as investable until confirmation is met and A) Execution submits/records an official working order.", "price": 62.19, "setup": "Qullamaggie Episodic Pivot", "status": "Lead intake", "stop": 55.25, "trigger": 62.42, "what_confirms": "Breakout through trigger on expanding volume", "what_kills": "Loss of recent structure / stop invalidation", "why_now": "Measured setup and leadership evidence qualified this candidate for research."}
Aug 19, 2026 20:05 UTC research Research cron update Decision: keep_in_lead_intake at score 72.0; setup Qullamaggie Episodic Pivot; trigger 62.42 / stop 55.25. Kevin Xu lens: volume 1.2813; catalyst/story Full-market query hit: leadership base, momentum flag, episodic pivot, sector relative strength; support/risk line defined. Kevin-style verbose research: 1. Lead source: TXG entered from full_market_scan; measured setup evidence initiated review. 2. Volume / attention: relative volume 1.2813 3. Catalyst / story: No verified catalyst recorded; the measured technical setup is the current reason for attention. 4. Comp / narrative analogy: No verified comparable-company framing recorded. 5. Chart / support line: Pattern Episodic pivot; price 62.19; trigger 62.42; stop/support 55.25; risk 11.49%. 5b. Measured setup validation: status not validated validated pattern none base duration 29 sessions base depth 33.547% range contraction not validly supplied pivot rejection 0.273% defects recorded: 1 6. O’Neil / quality gate: CANSLIM D / 44.76; missing C, A, N, I, M. 7. Verification gaps: validated Qullamaggie setup structure 8. Thesis alive/dead: Confirms: Breakout through trigger on expanding volume. Kills: Loss of recent structure / stop invalidation. Qullamaggie lens: Episodic pivot; confirmation requires price/volume continuation, not stale list repetition. O’Neil lens: CANSLIM D / 44.76; gate 🟡 Technical setup, fundamentals incomplete; pivot 62.42; sell rule 55.25. Still needs: validated Qullamaggie setup structure.
Aug 19, 2026 14:00 UTC history Historical thesis receipt {"chart_pattern": "Episodic pivot", "company": "10x Genomics, Inc.", "decision": "keep_in_lead_intake", "decision_reason": "Iris kept in lead intake after immediate research. Score 68. Still needs: validated Qullamaggie setup structure.", "narrative": "TXG: research only. No default size. Kevin-style research chain: 1. Lead source: TXG entered from full_market_scan; measured setup evidence initiated review. 2. Volume / attention: relative volume 0.2358 3. Catalyst / story: No verified catalyst recorded; the measured technical setup is the current reason for attention. 4. Comp / narrative analogy: No verified comparable-company framing recorded. 5. Chart / support line: Pattern Episodic pivot; price 59.44; trigger 61.31; stop/support 55.25; risk 9.88%. 5b. Measured setup validation: status not validated validated pattern none base duration 29 sessions base depth 32.343% range contraction 0.961 pivot rejection 2.955% defects recorded: 1 6. O\u2019Neil / quality gate: CANSLIM D / 41.9; missing C, A, N, I, M. 7. Verification gaps: validated Qullamaggie setup structure 8. Thesis alive/dead: Confirms: Breakout through trigger on expanding volume. Kills: Loss of recent structure / stop invalidation. CANSLIM/O\u2019Neil read: D / 41.9. Missing letters: C, A, N, I, M. Chart read: Episodic pivot (watch confidence). Trigger 61.31 Stop/invalidation 55.25. Current stance: kept in lead intake. Iris is not treating this as investable until confirmation is met and A) Execution submits/records an official working order.", "price": 59.44, "setup": "Qullamaggie Episodic Pivot", "status": "Lead intake", "stop": 55.25, "trigger": 61.31, "what_confirms": "Breakout through trigger on expanding volume", "what_kills": "Loss of recent structure / stop invalidation", "why_now": "Measured setup and leadership evidence qualified this candidate for research."}
Aug 19, 2026 14:00 UTC research Research cron update Decision: keep_in_lead_intake at score 68.0; setup Qullamaggie Episodic Pivot; trigger 61.31 / stop 55.25. Kevin Xu lens: volume 0.2358; catalyst/story Full-market query hit: leadership base, momentum flag, episodic pivot, sector relative strength; support/risk line defined. Kevin-style verbose research: 1. Lead source: TXG entered from full_market_scan; measured setup evidence initiated review. 2. Volume / attention: relative volume 0.2358 3. Catalyst / story: No verified catalyst recorded; the measured technical setup is the current reason for attention. 4. Comp / narrative analogy: No verified comparable-company framing recorded. 5. Chart / support line: Pattern Episodic pivot; price 59.44; trigger 61.31; stop/support 55.25; risk 9.88%. 5b. Measured setup validation: status not validated validated pattern none base duration 29 sessions base depth 32.343% range contraction 0.961 pivot rejection 2.955% defects recorded: 1 6. O’Neil / quality gate: CANSLIM D / 41.9; missing C, A, N, I, M. 7. Verification gaps: validated Qullamaggie setup structure 8. Thesis alive/dead: Confirms: Breakout through trigger on expanding volume. Kills: Loss of recent structure / stop invalidation. Qullamaggie lens: Episodic pivot; confirmation requires price/volume continuation, not stale list repetition. O’Neil lens: CANSLIM D / 41.9; gate 🟡 Technical setup, fundamentals incomplete; pivot 61.31; sell rule 55.25. Still needs: validated Qullamaggie setup structure.
Aug 18, 2026 14:00 UTC history Historical thesis receipt {"chart_pattern": "Pattern pending", "company": "10x Genomics, Inc.", "decision": "keep_in_lead_intake", "decision_reason": "Iris kept in lead intake after immediate research. Score 65. Still needs: verified catalyst.", "narrative": "TXG: research only. No default size. Kevin-style research chain: 1. Lead source: TXG entered from full_market_scan; measured setup evidence initiated review. 2. Volume / attention: relative volume 0.0492 3. Catalyst / story: No verified catalyst recorded; the measured technical setup is the current reason for attention. 4. Comp / narrative analogy: No verified comparable-company framing recorded. 5. Chart / support line: Pattern Pattern pending; price 58.635; trigger 60.75; stop/support 55.73; risk 8.26%. 5b. Measured setup validation: status not validated validated pattern none base duration 27 sessions base depth 31.719% range contraction 0.842 pivot rejection 3.641% defects recorded: 2 6. O\u2019Neil / quality gate: CANSLIM D / 41.9; missing C, A, N, I, M. 7. Verification gaps: verified catalyst 8. Thesis alive/dead: Confirms: Breakout through trigger on expanding volume. Kills: Loss of recent structure / stop invalidation. CANSLIM/O\u2019Neil read: D / 41.9. Missing letters: C, A, N, I, M. Chart read: Pattern pending (low confidence). Trigger 60.75 Stop/invalidation 55.73. Current stance: kept in lead intake. Iris is not treating this as investable until confirmation is met and A) Execution submits/records an official working order.", "price": 58.635, "setup": "Volatility Contraction", "status": "Lead intake", "stop": 55.73, "trigger": 60.75, "what_confirms": "Breakout through trigger on expanding volume", "what_kills": "Loss of recent structure / stop invalidation", "why_now": "Measured setup and leadership evidence qualified this candidate for research."}
Aug 18, 2026 14:00 UTC research Research cron update Decision: keep_in_lead_intake at score 65.0; setup Volatility Contraction; trigger 60.75 / stop 55.73. Kevin Xu lens: volume 0.0492; catalyst/story Full-market query hit: leadership base, sector relative strength; support/risk line defined. Kevin-style verbose research: 1. Lead source: TXG entered from full_market_scan; measured setup evidence initiated review. 2. Volume / attention: relative volume 0.0492 3. Catalyst / story: No verified catalyst recorded; the measured technical setup is the current reason for attention. 4. Comp / narrative analogy: No verified comparable-company framing recorded. 5. Chart / support line: Pattern Pattern pending; price 58.635; trigger 60.75; stop/support 55.73; risk 8.26%. 5b. Measured setup validation: status not validated validated pattern none base duration 27 sessions base depth 31.719% range contraction 0.842 pivot rejection 3.641% defects recorded: 2 6. O’Neil / quality gate: CANSLIM D / 41.9; missing C, A, N, I, M. 7. Verification gaps: verified catalyst 8. Thesis alive/dead: Confirms: Breakout through trigger on expanding volume. Kills: Loss of recent structure / stop invalidation. Qullamaggie lens: Pattern pending; confirmation requires price/volume continuation, not stale list repetition. O’Neil lens: CANSLIM D / 41.9; gate 🟡 Technical setup, fundamentals incomplete; pivot 60.75; sell rule 55.73. No new blocking research gaps from this pass.
Aug 12, 2026 14:00 UTC history Historical thesis receipt {"chart_pattern": "Pattern pending", "company": "10x Genomics, Inc.", "decision": "keep_in_lead_intake", "decision_reason": "Iris kept in lead intake after immediate research. Score 65. Still needs: verified catalyst.", "narrative": "TXG: research only. No default size. Kevin-style research chain: 1. Lead source: TXG entered from full_market_scan; measured setup evidence initiated review. 2. Volume / attention: relative volume 0.162 3. Catalyst / story: No verified catalyst recorded; the measured technical setup is the current reason for attention. 4. Comp / narrative analogy: No verified comparable-company framing recorded. 5. Chart / support line: Pattern Pattern pending; price 58.61; trigger 60.75; stop/support 53.57; risk 11.82%. 5b. Measured setup validation: status not validated validated pattern none base duration not validly supplied base depth not validly supplied range contraction not validly supplied pivot rejection 3.641% defects recorded: 1 6. O\u2019Neil / quality gate: CANSLIM D / 41.9; missing C, A, N, I, M. 7. Verification gaps: verified catalyst 8. Thesis alive/dead: Confirms: Breakout through trigger on expanding volume. Kills: Loss of recent structure / stop invalidation. CANSLIM/O\u2019Neil read: D / 41.9. Missing letters: C, A, N, I, M. Chart read: Pattern pending (low confidence). Trigger 60.75 Stop/invalidation 53.57. Current stance: kept in lead intake. Iris is not treating this as investable until confirmation is met and A) Execution submits/records an official working order.", "price": 58.61, "setup": "Volatility Contraction", "status": "Lead intake", "stop": 53.57, "trigger": 60.75, "what_confirms": "Breakout through trigger on expanding volume", "what_kills": "Loss of recent structure / stop invalidation", "why_now": "Measured setup and leadership evidence qualified this candidate for research."}
Aug 12, 2026 14:00 UTC research Research cron update Decision: keep_in_lead_intake at score 65.0; setup Volatility Contraction; trigger 60.75 / stop 53.57. Kevin Xu lens: volume 0.162; catalyst/story Full-market query hit: leadership base, sector relative strength; support/risk line defined. Kevin-style verbose research: 1. Lead source: TXG entered from full_market_scan; measured setup evidence initiated review. 2. Volume / attention: relative volume 0.162 3. Catalyst / story: No verified catalyst recorded; the measured technical setup is the current reason for attention. 4. Comp / narrative analogy: No verified comparable-company framing recorded. 5. Chart / support line: Pattern Pattern pending; price 58.61; trigger 60.75; stop/support 53.57; risk 11.82%. 5b. Measured setup validation: status not validated validated pattern none base duration not validly supplied base depth not validly supplied range contraction not validly supplied pivot rejection 3.641% defects recorded: 1 6. O’Neil / quality gate: CANSLIM D / 41.9; missing C, A, N, I, M. 7. Verification gaps: verified catalyst 8. Thesis alive/dead: Confirms: Breakout through trigger on expanding volume. Kills: Loss of recent structure / stop invalidation. Qullamaggie lens: Pattern pending; confirmation requires price/volume continuation, not stale list repetition. O’Neil lens: CANSLIM D / 41.9; gate 🟡 Technical setup, fundamentals incomplete; pivot 60.75; sell rule 53.57. No new blocking research gaps from this pass.
Aug 12, 2026 12:50 UTC history Historical thesis receipt {"chart_pattern": "Pattern pending", "company": "10x Genomics, Inc.", "decision": "keep_in_lead_intake", "decision_reason": "Iris kept in lead intake after immediate research. Score 69. Still needs: verified catalyst.", "narrative": "TXG: research only. No default size. Kevin-style research chain: 1. Lead source: TXG entered from full_market_scan; measured setup evidence initiated review. 2. Volume / attention: relative volume 1.3569 3. Catalyst / story: No verified catalyst recorded; the measured technical setup is the current reason for attention. 4. Comp / narrative analogy: No verified comparable-company framing recorded. 5. Chart / support line: Pattern Pattern pending; price 58.48; trigger 60.75; stop/support 53.47; risk 11.98%. 5b. Measured setup validation: status not validated validated pattern none base duration not validly supplied base depth not validly supplied range contraction not validly supplied pivot rejection 3.641% defects recorded: 1 6. O\u2019Neil / quality gate: CANSLIM D / 44.76; missing C, A, N, I, M. 7. Verification gaps: verified catalyst 8. Thesis alive/dead: Confirms: Breakout through trigger on expanding volume. Kills: Loss of recent structure / stop invalidation. CANSLIM/O\u2019Neil read: D / 44.76. Missing letters: C, A, N, I, M. Chart read: Pattern pending (low confidence). Trigger 60.75 Stop/invalidation 53.47. Current stance: kept in lead intake. Iris is not treating this as investable until confirmation is met and A) Execution submits/records an official working order.", "price": 58.48, "setup": "Volatility Contraction", "status": "Lead intake", "stop": 53.47, "trigger": 60.75, "what_confirms": "Breakout through trigger on expanding volume", "what_kills": "Loss of recent structure / stop invalidation", "why_now": "Measured setup and leadership evidence qualified this candidate for research."}
Aug 12, 2026 12:50 UTC research Research cron update Decision: keep_in_lead_intake at score 69.0; setup Volatility Contraction; trigger 60.75 / stop 53.47. Kevin Xu lens: volume 1.3569; catalyst/story Full-market query hit: leadership base, sector relative strength; support/risk line defined. Kevin-style verbose research: 1. Lead source: TXG entered from full_market_scan; measured setup evidence initiated review. 2. Volume / attention: relative volume 1.3569 3. Catalyst / story: No verified catalyst recorded; the measured technical setup is the current reason for attention. 4. Comp / narrative analogy: No verified comparable-company framing recorded. 5. Chart / support line: Pattern Pattern pending; price 58.48; trigger 60.75; stop/support 53.47; risk 11.98%. 5b. Measured setup validation: status not validated validated pattern none base duration not validly supplied base depth not validly supplied range contraction not validly supplied pivot rejection 3.641% defects recorded: 1 6. O’Neil / quality gate: CANSLIM D / 44.76; missing C, A, N, I, M. 7. Verification gaps: verified catalyst 8. Thesis alive/dead: Confirms: Breakout through trigger on expanding volume. Kills: Loss of recent structure / stop invalidation. Qullamaggie lens: Pattern pending; confirmation requires price/volume continuation, not stale list repetition. O’Neil lens: CANSLIM D / 44.76; gate 🟡 Technical setup, fundamentals incomplete; pivot 60.75; sell rule 53.47. No new blocking research gaps from this pass.
Aug 11, 2026 14:00 UTC history Historical thesis receipt {"chart_pattern": "Pattern pending", "company": "10x Genomics, Inc.", "decision": "keep_in_lead_intake", "decision_reason": "Iris kept in lead intake after immediate research. Score 65. Still needs: verified catalyst.", "narrative": "TXG: research only. No default size. Kevin-style research chain: 1. Lead source: TXG entered from full_market_scan; measured setup evidence initiated review. 2. Volume / attention: relative volume 0.2154 3. Catalyst / story: No verified catalyst recorded; the measured technical setup is the current reason for attention. 4. Comp / narrative analogy: No verified comparable-company framing recorded. 5. Chart / support line: Pattern Pattern pending; price 58.32; trigger 60.57; stop/support 53.31; risk 11.99%. 5b. Measured setup validation: status not validated validated pattern none base duration not validly supplied base depth not validly supplied range contraction not validly supplied pivot rejection 3.619% defects recorded: 1 6. O\u2019Neil / quality gate: CANSLIM D / 41.9; missing C, A, N, I, M. 7. Verification gaps: verified catalyst 8. Thesis alive/dead: Confirms: Breakout through trigger on expanding volume. Kills: Loss of recent structure / stop invalidation. CANSLIM/O\u2019Neil read: D / 41.9. Missing letters: C, A, N, I, M. Chart read: Pattern pending (low confidence). Trigger 60.57 Stop/invalidation 53.31. Current stance: kept in lead intake. Iris is not treating this as investable until confirmation is met and A) Execution submits/records an official working order.", "price": 58.32, "setup": "Volatility Contraction", "status": "Lead intake", "stop": 53.31, "trigger": 60.57, "what_confirms": "Breakout through trigger on expanding volume", "what_kills": "Loss of recent structure / stop invalidation", "why_now": "Measured setup and leadership evidence qualified this candidate for research."}
Aug 11, 2026 14:00 UTC research Research cron update Decision: keep_in_lead_intake at score 65.0; setup Volatility Contraction; trigger 60.57 / stop 53.31. Kevin Xu lens: volume 0.2154; catalyst/story Full-market query hit: leadership base, sector relative strength; support/risk line defined. Kevin-style verbose research: 1. Lead source: TXG entered from full_market_scan; measured setup evidence initiated review. 2. Volume / attention: relative volume 0.2154 3. Catalyst / story: No verified catalyst recorded; the measured technical setup is the current reason for attention. 4. Comp / narrative analogy: No verified comparable-company framing recorded. 5. Chart / support line: Pattern Pattern pending; price 58.32; trigger 60.57; stop/support 53.31; risk 11.99%. 5b. Measured setup validation: status not validated validated pattern none base duration not validly supplied base depth not validly supplied range contraction not validly supplied pivot rejection 3.619% defects recorded: 1 6. O’Neil / quality gate: CANSLIM D / 41.9; missing C, A, N, I, M. 7. Verification gaps: verified catalyst 8. Thesis alive/dead: Confirms: Breakout through trigger on expanding volume. Kills: Loss of recent structure / stop invalidation. Qullamaggie lens: Pattern pending; confirmation requires price/volume continuation, not stale list repetition. O’Neil lens: CANSLIM D / 41.9; gate 🟡 Technical setup, fundamentals incomplete; pivot 60.57; sell rule 53.31. No new blocking research gaps from this pass.
Aug 11, 2026 12:50 UTC history Historical thesis receipt {"chart_pattern": "Episodic pivot", "company": "10x Genomics, Inc.", "decision": "keep_in_lead_intake", "decision_reason": "Iris kept in lead intake after immediate research. Score 75. Still needs: validated Qullamaggie setup structure.", "narrative": "TXG: research only. No default size. Kevin-style research chain: 1. Lead source: TXG entered from full_market_scan; measured setup evidence initiated review. 2. Volume / attention: relative volume 1.9851 3. Catalyst / story: No verified catalyst recorded; the measured technical setup is the current reason for attention. 4. Comp / narrative analogy: No verified comparable-company framing recorded. 5. Chart / support line: Pattern Episodic pivot; price 58.57; trigger 59.93; stop/support 52.87; risk 11.78%. 5b. Measured setup validation: status not validated validated pattern none base duration not validly supplied base depth not validly supplied range contraction not validly supplied pivot rejection 2.171% defects recorded: 1 6. O\u2019Neil / quality gate: CANSLIM D / 49.52; missing C, A, N, I, M. 7. Verification gaps: validated Qullamaggie setup structure 8. Thesis alive/dead: Confirms: Breakout through trigger on expanding volume. Kills: Loss of recent structure / stop invalidation. CANSLIM/O\u2019Neil read: D / 49.52. Missing letters: C, A, N, I, M. Chart read: Episodic pivot (watch confidence). Trigger 59.93 Stop/invalidation 52.87. Current stance: kept in lead intake. Iris is not treating this as investable until confirmation is met and A) Execution submits/records an official working order.", "price": 58.57, "setup": "Qullamaggie Episodic Pivot", "status": "Lead intake", "stop": 52.87, "trigger": 59.93, "what_confirms": "Breakout through trigger on expanding volume", "what_kills": "Loss of recent structure / stop invalidation", "why_now": "Measured setup and leadership evidence qualified this candidate for research."}
Aug 11, 2026 12:50 UTC research Research cron update Decision: keep_in_lead_intake at score 75.0; setup Qullamaggie Episodic Pivot; trigger 59.93 / stop 52.87. Kevin Xu lens: volume 1.9851; catalyst/story Full-market query hit: leadership base, momentum flag, episodic pivot, sector relative strength; support/risk line defined. Kevin-style verbose research: 1. Lead source: TXG entered from full_market_scan; measured setup evidence initiated review. 2. Volume / attention: relative volume 1.9851 3. Catalyst / story: No verified catalyst recorded; the measured technical setup is the current reason for attention. 4. Comp / narrative analogy: No verified comparable-company framing recorded. 5. Chart / support line: Pattern Episodic pivot; price 58.57; trigger 59.93; stop/support 52.87; risk 11.78%. 5b. Measured setup validation: status not validated validated pattern none base duration not validly supplied base depth not validly supplied range contraction not validly supplied pivot rejection 2.171% defects recorded: 1 6. O’Neil / quality gate: CANSLIM D / 49.52; missing C, A, N, I, M. 7. Verification gaps: validated Qullamaggie setup structure 8. Thesis alive/dead: Confirms: Breakout through trigger on expanding volume. Kills: Loss of recent structure / stop invalidation. Qullamaggie lens: Episodic pivot; confirmation requires price/volume continuation, not stale list repetition. O’Neil lens: CANSLIM D / 49.52; gate 🟡 Technical setup, fundamentals incomplete; pivot 59.93; sell rule 52.87. Still needs: validated Qullamaggie setup structure.
Aug 10, 2026 14:00 UTC history Historical thesis receipt {"chart_pattern": "Pattern pending", "company": "10x Genomics, Inc.", "decision": "keep_in_lead_intake", "decision_reason": "Iris kept in lead intake after immediate research. Score 65. Still needs: verified catalyst.", "narrative": "TXG: research only. No default size. Kevin-style research chain: 1. Lead source: TXG entered from full_market_scan; measured setup evidence initiated review. 2. Volume / attention: relative volume 0.1334 3. Catalyst / story: No verified catalyst recorded; the measured technical setup is the current reason for attention. 4. Comp / narrative analogy: No verified comparable-company framing recorded. 5. Chart / support line: Pattern Pattern pending; price 54.23; trigger 54.99; stop/support 48.63; risk 11.57%. 5b. Measured setup validation: status not validated validated pattern none base duration not validly supplied base depth not validly supplied range contraction not validly supplied pivot rejection 1.292% defects recorded: 1 6. O\u2019Neil / quality gate: CANSLIM D / 41.9; missing C, A, N, I, M. 7. Verification gaps: verified catalyst 8. Thesis alive/dead: Confirms: Breakout through trigger on expanding volume. Kills: Loss of recent structure / stop invalidation. CANSLIM/O\u2019Neil read: D / 41.9. Missing letters: C, A, N, I, M. Chart read: Pattern pending (low confidence). Trigger 54.99 Stop/invalidation 48.63. Current stance: kept in lead intake. Iris is not treating this as investable until confirmation is met and A) Execution submits/records an official working order.", "price": 54.23, "setup": "Volatility Contraction", "status": "Lead intake", "stop": 48.63, "trigger": 54.99, "what_confirms": "Breakout through trigger on expanding volume", "what_kills": "Loss of recent structure / stop invalidation", "why_now": "Measured setup and leadership evidence qualified this candidate for research."}
Aug 10, 2026 14:00 UTC research Research cron update Decision: keep_in_lead_intake at score 65.0; setup Volatility Contraction; trigger 54.99 / stop 48.63. Kevin Xu lens: volume 0.1334; catalyst/story Full-market query hit: leadership base, sector relative strength; support/risk line defined. Kevin-style verbose research: 1. Lead source: TXG entered from full_market_scan; measured setup evidence initiated review. 2. Volume / attention: relative volume 0.1334 3. Catalyst / story: No verified catalyst recorded; the measured technical setup is the current reason for attention. 4. Comp / narrative analogy: No verified comparable-company framing recorded. 5. Chart / support line: Pattern Pattern pending; price 54.23; trigger 54.99; stop/support 48.63; risk 11.57%. 5b. Measured setup validation: status not validated validated pattern none base duration not validly supplied base depth not validly supplied range contraction not validly supplied pivot rejection 1.292% defects recorded: 1 6. O’Neil / quality gate: CANSLIM D / 41.9; missing C, A, N, I, M. 7. Verification gaps: verified catalyst 8. Thesis alive/dead: Confirms: Breakout through trigger on expanding volume. Kills: Loss of recent structure / stop invalidation. Qullamaggie lens: Pattern pending; confirmation requires price/volume continuation, not stale list repetition. O’Neil lens: CANSLIM D / 41.9; gate 🟡 Technical setup, fundamentals incomplete; pivot 54.99; sell rule 48.63. No new blocking research gaps from this pass.
Aug 10, 2026 12:50 UTC history Historical thesis receipt {"chart_pattern": "Episodic pivot", "company": "10x Genomics, Inc.", "decision": "promote_to_tracking", "decision_reason": "Iris promoted to Tracking after immediate research. Score 75. Still needs: verified catalyst.", "narrative": "TXG is a 31-session episodic pivot and pressing the 52.27 pivot; candidate-pool leadership at 98 and 144.0% three-month outperformance earned it a spot on the board. Kevin-style research chain: 1. Lead source: TXG entered from full_market_scan; measured setup evidence initiated review. 2. Volume / attention: relative volume 1.88 3. Catalyst / story: No verified catalyst recorded; the measured technical setup is the current reason for attention. 4. Comp / narrative analogy: No verified comparable-company framing recorded. 5. Chart / support line: Pattern Episodic pivot; price 52.03; trigger 52.27; stop/support 45.74; risk 12.49%. 5b. Measured setup validation: status not validated validated pattern none base duration 31 sessions base depth 33.943% range contraction not validly supplied pivot rejection 0.364% defects recorded: 1 6. O\u2019Neil / quality gate: CANSLIM D / 49.52; missing C, A, N, I, M. 7. Verification gaps: verified catalyst 8. Thesis alive/dead: Confirms: Breakout through trigger on expanding volume. Kills: Loss of recent structure / stop invalidation. CANSLIM/O\u2019Neil read: D / 49.52. Missing letters: C, A, N, I, M. Chart read: Episodic pivot (watch confidence). Trigger 52.27 Stop/invalidation 45.74. Current stance: Tracking only; sizing and any order remain gated by Order Ready authorization and A) Execution.", "price": 52.03, "setup": "Qullamaggie Episodic Pivot", "status": "Tracking candidate", "stop": 45.74, "trigger": 52.27, "what_confirms": "Breakout through trigger on expanding volume", "what_kills": "Loss of recent structure / stop invalidation", "why_now": "Measured price structure and leadership evidence earned the setup a place on the board. Price remains above its 50-day and 200-day averages. Confirmation: Breakout through trigger on expanding volume. Invalidation: Loss of recent structure / stop invalidation."}
Aug 10, 2026 12:50 UTC research Research cron update Decision: promote_to_tracking at score 75.0; setup Qullamaggie Episodic Pivot; trigger 52.27 / stop 45.74. Kevin Xu lens: volume 1.88; catalyst/story Full-market query hit: leadership base, momentum flag, episodic pivot, sector relative strength; support/risk line defined. Kevin-style verbose research: 1. Lead source: TXG entered from full_market_scan; measured setup evidence initiated review. 2. Volume / attention: relative volume 1.88 3. Catalyst / story: No verified catalyst recorded; the measured technical setup is the current reason for attention. 4. Comp / narrative analogy: No verified comparable-company framing recorded. 5. Chart / support line: Pattern Episodic pivot; price 52.03; trigger 52.27; stop/support 45.74; risk 12.49%. 5b. Measured setup validation: status not validated validated pattern none base duration 31 sessions base depth 33.943% range contraction not validly supplied pivot rejection 0.364% defects recorded: 1 6. O’Neil / quality gate: CANSLIM D / 49.52; missing C, A, N, I, M. 7. Verification gaps: verified catalyst 8. Thesis alive/dead: Confirms: Breakout through trigger on expanding volume. Kills: Loss of recent structure / stop invalidation. Qullamaggie lens: Episodic pivot; confirmation requires price/volume continuation, not stale list repetition. O’Neil lens: CANSLIM D / 49.52; gate 🟡 Technical setup, fundamentals incomplete; pivot 52.27; sell rule 45.74. No new blocking research gaps from this pass.
Aug 5, 2026 14:00 UTC history Historical thesis receipt {"chart_pattern": "Pattern pending", "company": "10x Genomics, Inc.", "decision": "keep_in_lead_intake", "decision_reason": "Iris kept in lead intake after immediate research. Score 65. Still needs: verified catalyst.", "narrative": "TXG: research only. No default size. Kevin-style research chain: 1. Lead source: TXG entered from full_market_scan; measured setup evidence initiated review. 2. Volume / attention: relative volume 0.0396 3. Catalyst / story: No verified catalyst recorded; the measured technical setup is the current reason for attention. 4. Comp / narrative analogy: No verified comparable-company framing recorded. 5. Chart / support line: Pattern Pattern pending; price 48.42; trigger 50.39; stop/support 45.21; risk 10.28%. 5b. Measured setup validation: status not validated validated pattern none base duration 29 sessions base depth 31.476% range contraction 0.943 pivot rejection 6.099% defects recorded: 2 6. O\u2019Neil / quality gate: CANSLIM D / 41.9; missing C, A, N, I, M. 7. Verification gaps: verified catalyst 8. Thesis alive/dead: Confirms: Breakout through trigger on expanding volume. Kills: Loss of recent structure / stop invalidation. CANSLIM/O\u2019Neil read: D / 41.9. Missing letters: C, A, N, I, M. Chart read: Pattern pending (low confidence). Trigger 50.39 Stop/invalidation 45.21. Current stance: kept in lead intake. Iris is not treating this as investable until confirmation is met and A) Execution submits/records an official working order.", "price": 48.42, "setup": "Volatility Contraction", "status": "Lead intake", "stop": 45.21, "trigger": 50.39, "what_confirms": "Breakout through trigger on expanding volume", "what_kills": "Loss of recent structure / stop invalidation", "why_now": "Measured setup and leadership evidence qualified this candidate for research."}
Aug 5, 2026 14:00 UTC research Research cron update Decision: keep_in_lead_intake at score 65.0; setup Volatility Contraction; trigger 50.39 / stop 45.21. Kevin Xu lens: volume 0.0396; catalyst/story Full-market query hit: leadership base; support/risk line defined. Kevin-style verbose research: 1. Lead source: TXG entered from full_market_scan; measured setup evidence initiated review. 2. Volume / attention: relative volume 0.0396 3. Catalyst / story: No verified catalyst recorded; the measured technical setup is the current reason for attention. 4. Comp / narrative analogy: No verified comparable-company framing recorded. 5. Chart / support line: Pattern Pattern pending; price 48.42; trigger 50.39; stop/support 45.21; risk 10.28%. 5b. Measured setup validation: status not validated validated pattern none base duration 29 sessions base depth 31.476% range contraction 0.943 pivot rejection 6.099% defects recorded: 2 6. O’Neil / quality gate: CANSLIM D / 41.9; missing C, A, N, I, M. 7. Verification gaps: verified catalyst 8. Thesis alive/dead: Confirms: Breakout through trigger on expanding volume. Kills: Loss of recent structure / stop invalidation. Qullamaggie lens: Pattern pending; confirmation requires price/volume continuation, not stale list repetition. O’Neil lens: CANSLIM D / 41.9; gate 🟡 Technical setup, fundamentals incomplete; pivot 50.39; sell rule 45.21. No new blocking research gaps from this pass.
Jul 31, 2026 14:00 UTC history Historical thesis receipt {"chart_pattern": "Pattern pending", "company": "10x Genomics, Inc.", "decision": "keep_in_lead_intake", "decision_reason": "Iris kept in lead intake after immediate research. Score 65. Still needs: verified catalyst.", "narrative": "TXG entered the lead file from full_market_scan because Full-market query hit: leadership base, sector relative strength. Kevin-style research chain: 1. Lead source: TXG entered from full_market_scan: Full-market query hit: leadership base, sector relative strength. 2. Volume / attention: relative volume 0.0794 RS rating 0 3. Catalyst / story: Full-market query hit: leadership base, sector relative strength 4. Comp / narrative analogy: No explicit comp supplied; analyst must identify the closest leader/peer before sizing conviction. 5. Chart / support line: Pattern Pattern pending; price 49.32; trigger 50.39; stop/support 45.01; risk 10.68%. 5b. Measured setup validation: status invalid validated pattern none base duration 26 sessions base depth 31.476% range contraction 0.933 pivot rejection 2.026% defects: recent ranges did not contract sufficiently 6. O\u2019Neil / quality gate: CANSLIM D / 41.9; missing C, A, N, I, M. 7. Verification gaps: verified catalyst 8. Thesis alive/dead: Confirms: Breakout through trigger on expanding volume. Kills: Loss of recent structure / stop invalidation. CANSLIM/O\u2019Neil read: D / 41.9. Missing letters: C, A, N, I, M. Chart read: Pattern pending (low confidence). Trigger 50.39 Stop/invalidation 45.01. Current stance: kept in lead intake. Iris is not treating this as investable until confirmation is met and A) Execution submits/records an official working order.", "price": 49.32, "setup": "Volatility Contraction", "status": "Lead intake", "stop": 45.01, "trigger": 50.39, "what_confirms": "Breakout through trigger on expanding volume", "what_kills": "Loss of recent structure / stop invalidation", "why_now": "Full-market query hit: leadership base, sector relative strength"}
Jul 31, 2026 14:00 UTC research Research cron update Decision: keep_in_lead_intake at score 65.0; setup Volatility Contraction; trigger 50.39 / stop 45.01. Kevin Xu lens: volume 0.0794; catalyst/story Full-market query hit: leadership base, sector relative strength; support/risk line defined. Kevin-style verbose research: 1. Lead source: TXG entered from full_market_scan: Full-market query hit: leadership base, sector relative strength. 2. Volume / attention: relative volume 0.0794 RS rating 0 3. Catalyst / story: Full-market query hit: leadership base, sector relative strength 4. Comp / narrative analogy: No explicit comp supplied; analyst must identify the closest leader/peer before sizing conviction. 5. Chart / support line: Pattern Pattern pending; price 49.32; trigger 50.39; stop/support 45.01; risk 10.68%. 5b. Measured setup validation: status invalid validated pattern none base duration 26 sessions base depth 31.476% range contraction 0.933 pivot rejection 2.026% defects: recent ranges did not contract sufficiently 6. O’Neil / quality gate: CANSLIM D / 41.9; missing C, A, N, I, M. 7. Verification gaps: verified catalyst 8. Thesis alive/dead: Confirms: Breakout through trigger on expanding volume. Kills: Loss of recent structure / stop invalidation. Qullamaggie lens: Pattern pending; confirmation requires price/volume continuation, not stale list repetition. O’Neil lens: CANSLIM D / 41.9; gate 🟡 Technical setup, fundamentals incomplete; pivot 50.39; sell rule 45.01. No new blocking research gaps from this pass.
Jul 31, 2026 12:50 UTC history Historical thesis receipt {"chart_pattern": "Pattern pending", "company": "10x Genomics, Inc.", "decision": "keep_in_lead_intake", "decision_reason": "Iris kept in lead intake after immediate research. Score 65. Still needs: verified catalyst.", "narrative": "TXG entered the lead file from full_market_scan because Full-market query hit: leadership base, sector relative strength. Kevin-style research chain: 1. Lead source: TXG entered from full_market_scan: Full-market query hit: leadership base, sector relative strength. 2. Volume / attention: relative volume 0.7721 RS rating 0 3. Catalyst / story: Full-market query hit: leadership base, sector relative strength 4. Comp / narrative analogy: No explicit comp supplied; analyst must identify the closest leader/peer before sizing conviction. 5. Chart / support line: Pattern Pattern pending; price 49.43; trigger 49.89; stop/support 45.01; risk 9.78%. 5b. Measured setup validation: status invalid validated pattern none base duration 26 sessions base depth 34.49% range contraction 1.025 pivot rejection 0.823% defects: recent ranges did not contract sufficiently 6. O\u2019Neil / quality gate: CANSLIM D / 44.76; missing C, A, N, I, M. 7. Verification gaps: verified catalyst 8. Thesis alive/dead: Confirms: Breakout through trigger on expanding volume. Kills: Loss of recent structure / stop invalidation. CANSLIM/O\u2019Neil read: D / 44.76. Missing letters: C, A, N, I, M. Chart read: Pattern pending (low confidence). Trigger 49.89 Stop/invalidation 45.01. Current stance: kept in lead intake. Iris is not treating this as investable until confirmation is met and A) Execution submits/records an official working order.", "price": 49.43, "setup": "Volatility Contraction", "status": "Lead intake", "stop": 45.01, "trigger": 49.89, "what_confirms": "Breakout through trigger on expanding volume", "what_kills": "Loss of recent structure / stop invalidation", "why_now": "Full-market query hit: leadership base, sector relative strength"}
Jul 31, 2026 12:50 UTC research Research cron update Decision: keep_in_lead_intake at score 65.0; setup Volatility Contraction; trigger 49.89 / stop 45.01. Kevin Xu lens: volume 0.7721; catalyst/story Full-market query hit: leadership base, sector relative strength; support/risk line defined. Kevin-style verbose research: 1. Lead source: TXG entered from full_market_scan: Full-market query hit: leadership base, sector relative strength. 2. Volume / attention: relative volume 0.7721 RS rating 0 3. Catalyst / story: Full-market query hit: leadership base, sector relative strength 4. Comp / narrative analogy: No explicit comp supplied; analyst must identify the closest leader/peer before sizing conviction. 5. Chart / support line: Pattern Pattern pending; price 49.43; trigger 49.89; stop/support 45.01; risk 9.78%. 5b. Measured setup validation: status invalid validated pattern none base duration 26 sessions base depth 34.49% range contraction 1.025 pivot rejection 0.823% defects: recent ranges did not contract sufficiently 6. O’Neil / quality gate: CANSLIM D / 44.76; missing C, A, N, I, M. 7. Verification gaps: verified catalyst 8. Thesis alive/dead: Confirms: Breakout through trigger on expanding volume. Kills: Loss of recent structure / stop invalidation. Qullamaggie lens: Pattern pending; confirmation requires price/volume continuation, not stale list repetition. O’Neil lens: CANSLIM D / 44.76; gate 🟡 Technical setup, fundamentals incomplete; pivot 49.89; sell rule 45.01. No new blocking research gaps from this pass.
Jul 30, 2026 20:05 UTC history Historical thesis receipt {"chart_pattern": "Pattern pending", "company": "10x Genomics, Inc.", "decision": "keep_in_lead_intake", "decision_reason": "Iris kept in lead intake after immediate research. Score 65. Still needs: verified catalyst.", "narrative": "TXG entered the lead file from full_market_scan because Full-market query hit: leadership base. Kevin-style research chain: 1. Lead source: TXG entered from full_market_scan: Full-market query hit: leadership base. 2. Volume / attention: relative volume 0.7536 RS rating 0 3. Catalyst / story: Full-market query hit: leadership base 4. Comp / narrative analogy: No explicit comp supplied; analyst must identify the closest leader/peer before sizing conviction. 5. Chart / support line: Pattern Pattern pending; price 49.43; trigger 49.88; stop/support 45.01; risk 9.76%. 5b. Measured setup validation: status invalid validated pattern none base duration 26 sessions base depth 34.477% range contraction 1.024 pivot rejection 0.803% defects: recent ranges did not contract sufficiently 6. O\u2019Neil / quality gate: CANSLIM D / 44.76; missing C, A, N, I, M. 7. Verification gaps: verified catalyst 8. Thesis alive/dead: Confirms: Breakout through trigger on expanding volume. Kills: Loss of recent structure / stop invalidation. CANSLIM/O\u2019Neil read: D / 44.76. Missing letters: C, A, N, I, M. Chart read: Pattern pending (low confidence). Trigger 49.88 Stop/invalidation 45.01. Current stance: kept in lead intake. Iris is not treating this as investable until confirmation is met and A) Execution submits/records an official working order.", "price": 49.43, "setup": "Volatility Contraction", "status": "Lead intake", "stop": 45.01, "trigger": 49.88, "what_confirms": "Breakout through trigger on expanding volume", "what_kills": "Loss of recent structure / stop invalidation", "why_now": "Full-market query hit: leadership base"}
Jul 30, 2026 20:05 UTC research Research cron update Decision: keep_in_lead_intake at score 65.0; setup Volatility Contraction; trigger 49.88 / stop 45.01. Kevin Xu lens: volume 0.7536; catalyst/story Full-market query hit: leadership base; support/risk line defined. Kevin-style verbose research: 1. Lead source: TXG entered from full_market_scan: Full-market query hit: leadership base. 2. Volume / attention: relative volume 0.7536 RS rating 0 3. Catalyst / story: Full-market query hit: leadership base 4. Comp / narrative analogy: No explicit comp supplied; analyst must identify the closest leader/peer before sizing conviction. 5. Chart / support line: Pattern Pattern pending; price 49.43; trigger 49.88; stop/support 45.01; risk 9.76%. 5b. Measured setup validation: status invalid validated pattern none base duration 26 sessions base depth 34.477% range contraction 1.024 pivot rejection 0.803% defects: recent ranges did not contract sufficiently 6. O’Neil / quality gate: CANSLIM D / 44.76; missing C, A, N, I, M. 7. Verification gaps: verified catalyst 8. Thesis alive/dead: Confirms: Breakout through trigger on expanding volume. Kills: Loss of recent structure / stop invalidation. Qullamaggie lens: Pattern pending; confirmation requires price/volume continuation, not stale list repetition. O’Neil lens: CANSLIM D / 44.76; gate 🟡 Technical setup, fundamentals incomplete; pivot 49.88; sell rule 45.01. No new blocking research gaps from this pass.
Jul 30, 2026 14:00 UTC history Historical thesis receipt {"chart_pattern": "Pattern pending", "company": "10x Genomics, Inc.", "decision": "keep_in_lead_intake", "decision_reason": "Iris kept in lead intake after immediate research. Score 65. Still needs: verified catalyst.", "narrative": "TXG entered the lead file from full_market_scan because Full-market query hit: leadership base. Kevin-style research chain: 1. Lead source: TXG entered from full_market_scan: Full-market query hit: leadership base. 2. Volume / attention: relative volume 0.0424 RS rating 0 3. Catalyst / story: Full-market query hit: leadership base 4. Comp / narrative analogy: No explicit comp supplied; analyst must identify the closest leader/peer before sizing conviction. 5. Chart / support line: Pattern Pattern pending; price 48.21; trigger 49.55; stop/support 45.01; risk 9.16%. 5b. Measured setup validation: status invalid validated pattern none base duration 26 sessions base depth 34.04% range contraction 0.904 pivot rejection 5.126% defects: recent ranges did not contract sufficiently; pivot rejection exceeded 3% high-to-close 6. O\u2019Neil / quality gate: CANSLIM D / 41.9; missing C, A, N, I, M. 7. Verification gaps: verified catalyst 8. Thesis alive/dead: Confirms: Breakout through trigger on expanding volume. Kills: Loss of recent structure / stop invalidation. CANSLIM/O\u2019Neil read: D / 41.9. Missing letters: C, A, N, I, M. Chart read: Pattern pending (low confidence). Trigger 49.55 Stop/invalidation 45.01. Current stance: kept in lead intake. Iris is not treating this as investable until confirmation is met and A) Execution submits/records an official working order.", "price": 48.21, "setup": "Volatility Contraction", "status": "Lead intake", "stop": 45.01, "trigger": 49.55, "what_confirms": "Breakout through trigger on expanding volume", "what_kills": "Loss of recent structure / stop invalidation", "why_now": "Full-market query hit: leadership base"}
Jul 30, 2026 14:00 UTC research Research cron update Decision: keep_in_lead_intake at score 65.0; setup Volatility Contraction; trigger 49.55 / stop 45.01. Kevin Xu lens: volume 0.0424; catalyst/story Full-market query hit: leadership base; support/risk line defined. Kevin-style verbose research: 1. Lead source: TXG entered from full_market_scan: Full-market query hit: leadership base. 2. Volume / attention: relative volume 0.0424 RS rating 0 3. Catalyst / story: Full-market query hit: leadership base 4. Comp / narrative analogy: No explicit comp supplied; analyst must identify the closest leader/peer before sizing conviction. 5. Chart / support line: Pattern Pattern pending; price 48.21; trigger 49.55; stop/support 45.01; risk 9.16%. 5b. Measured setup validation: status invalid validated pattern none base duration 26 sessions base depth 34.04% range contraction 0.904 pivot rejection 5.126% defects: recent ranges did not contract sufficiently; pivot rejection exceeded 3% high-to-close 6. O’Neil / quality gate: CANSLIM D / 41.9; missing C, A, N, I, M. 7. Verification gaps: verified catalyst 8. Thesis alive/dead: Confirms: Breakout through trigger on expanding volume. Kills: Loss of recent structure / stop invalidation. Qullamaggie lens: Pattern pending; confirmation requires price/volume continuation, not stale list repetition. O’Neil lens: CANSLIM D / 41.9; gate 🟡 Technical setup, fundamentals incomplete; pivot 49.55; sell rule 45.01. No new blocking research gaps from this pass.
Jul 29, 2026 14:00 UTC history Historical thesis receipt {"chart_pattern": "Pattern pending", "company": "10x Genomics, Inc.", "decision": "keep_in_lead_intake", "decision_reason": "Iris kept in lead intake after immediate research. Score 65. Still needs: verified catalyst.", "narrative": "TXG entered the lead file from full_market_scan because Full-market query hit: leadership base. Kevin-style research chain: 1. Lead source: TXG entered from full_market_scan: Full-market query hit: leadership base. 2. Volume / attention: relative volume 0.0639 RS rating 0 3. Catalyst / story: Full-market query hit: leadership base 4. Comp / narrative analogy: No explicit comp supplied; analyst must identify the closest leader/peer before sizing conviction. 5. Chart / support line: Pattern Pattern pending; price 47.53; trigger 49.55; stop/support 45.01; risk 9.16%. 5b. Measured setup validation: status invalid validated pattern none base duration 25 sessions base depth 34.04% range contraction 0.913 pivot rejection 2.909% defects: recent ranges did not contract sufficiently 6. O\u2019Neil / quality gate: CANSLIM D / 41.9; missing C, A, N, I, M. 7. Verification gaps: verified catalyst 8. Thesis alive/dead: Confirms: Breakout through trigger on expanding volume. Kills: Loss of recent structure / stop invalidation. CANSLIM/O\u2019Neil read: D / 41.9. Missing letters: C, A, N, I, M. Chart read: Pattern pending (low confidence). Trigger 49.55 Stop/invalidation 45.01. Current stance: kept in lead intake. Iris is not treating this as investable until confirmation is met and A) Execution submits/records an official working order.", "price": 47.53, "setup": "Volatility Contraction", "status": "Lead intake", "stop": 45.01, "trigger": 49.55, "what_confirms": "Breakout through trigger on expanding volume", "what_kills": "Loss of recent structure / stop invalidation", "why_now": "Full-market query hit: leadership base"}
Jul 29, 2026 14:00 UTC research Research cron update Decision: keep_in_lead_intake at score 65.0; setup Volatility Contraction; trigger 49.55 / stop 45.01. Kevin Xu lens: volume 0.0639; catalyst/story Full-market query hit: leadership base; support/risk line defined. Kevin-style verbose research: 1. Lead source: TXG entered from full_market_scan: Full-market query hit: leadership base. 2. Volume / attention: relative volume 0.0639 RS rating 0 3. Catalyst / story: Full-market query hit: leadership base 4. Comp / narrative analogy: No explicit comp supplied; analyst must identify the closest leader/peer before sizing conviction. 5. Chart / support line: Pattern Pattern pending; price 47.53; trigger 49.55; stop/support 45.01; risk 9.16%. 5b. Measured setup validation: status invalid validated pattern none base duration 25 sessions base depth 34.04% range contraction 0.913 pivot rejection 2.909% defects: recent ranges did not contract sufficiently 6. O’Neil / quality gate: CANSLIM D / 41.9; missing C, A, N, I, M. 7. Verification gaps: verified catalyst 8. Thesis alive/dead: Confirms: Breakout through trigger on expanding volume. Kills: Loss of recent structure / stop invalidation. Qullamaggie lens: Pattern pending; confirmation requires price/volume continuation, not stale list repetition. O’Neil lens: CANSLIM D / 41.9; gate 🟡 Technical setup, fundamentals incomplete; pivot 49.55; sell rule 45.01. No new blocking research gaps from this pass.
Jul 23, 2026 14:00 UTC history Historical thesis receipt {"chart_pattern": "Pattern pending", "company": "10x Genomics, Inc.", "decision": "keep_in_lead_intake", "decision_reason": "Iris kept in lead intake after immediate research. Score 65. Still needs: verified catalyst.", "narrative": "TXG entered the lead file from full_market_scan because Full-market query hit: leadership base. Kevin-style research chain: 1. Lead source: TXG entered from full_market_scan: Full-market query hit: leadership base. 2. Volume / attention: relative volume 0.0824 RS rating 0 3. Catalyst / story: Full-market query hit: leadership base 4. Comp / narrative analogy: No explicit comp supplied; analyst must identify the closest leader/peer before sizing conviction. 5. Chart / support line: Pattern Pattern pending; price 48.655; trigger 49.55; stop/support 43.56; risk 12.09%. 5b. Measured setup validation: status insufficient_evidence validated pattern none base duration None sessions base depth None% range contraction 1.052 pivot rejection 1.707% defects: measured base duration/depth/tightness and pivot behavior are required 6. O\u2019Neil / quality gate: CANSLIM D / 41.9; missing C, A, N, I, M. 7. Verification gaps: verified catalyst 8. Thesis alive/dead: Confirms: Breakout through trigger on expanding volume. Kills: Loss of recent structure / stop invalidation. CANSLIM/O\u2019Neil read: D / 41.9. Missing letters: C, A, N, I, M. Chart read: Pattern pending (low confidence). Trigger 49.55 Stop/invalidation 43.56. Current stance: kept in lead intake. Iris is not treating this as investable until confirmation is met and A) Execution submits/records an official working order.", "price": 48.655, "setup": "Volatility Contraction", "status": "Lead intake", "stop": 43.56, "trigger": 49.55, "what_confirms": "Breakout through trigger on expanding volume", "what_kills": "Loss of recent structure / stop invalidation", "why_now": "Full-market query hit: leadership base"}
Jul 23, 2026 14:00 UTC research Research cron update Decision: keep_in_lead_intake at score 65.0; setup Volatility Contraction; trigger 49.55 / stop 43.56. Kevin Xu lens: volume 0.0824; catalyst/story Full-market query hit: leadership base; support/risk line defined. Kevin-style verbose research: 1. Lead source: TXG entered from full_market_scan: Full-market query hit: leadership base. 2. Volume / attention: relative volume 0.0824 RS rating 0 3. Catalyst / story: Full-market query hit: leadership base 4. Comp / narrative analogy: No explicit comp supplied; analyst must identify the closest leader/peer before sizing conviction. 5. Chart / support line: Pattern Pattern pending; price 48.655; trigger 49.55; stop/support 43.56; risk 12.09%. 5b. Measured setup validation: status insufficient_evidence validated pattern none base duration None sessions base depth None% range contraction 1.052 pivot rejection 1.707% defects: measured base duration/depth/tightness and pivot behavior are required 6. O’Neil / quality gate: CANSLIM D / 41.9; missing C, A, N, I, M. 7. Verification gaps: verified catalyst 8. Thesis alive/dead: Confirms: Breakout through trigger on expanding volume. Kills: Loss of recent structure / stop invalidation. Qullamaggie lens: Pattern pending; confirmation requires price/volume continuation, not stale list repetition. O’Neil lens: CANSLIM D / 41.9; gate 🟡 Technical setup, fundamentals incomplete; pivot 49.55; sell rule 43.56. No new blocking research gaps from this pass.
Jul 23, 2026 12:50 UTC history Historical thesis receipt {"chart_pattern": "Pattern pending", "company": "10x Genomics, Inc.", "decision": "keep_in_lead_intake", "decision_reason": "Iris kept in lead intake after immediate research. Score 65. Still needs: verified catalyst.", "narrative": "TXG entered the lead file from full_market_scan because Full-market query hit: leadership base. Kevin-style research chain: 1. Lead source: TXG entered from full_market_scan: Full-market query hit: leadership base. 2. Volume / attention: relative volume 0.8467 RS rating 0 3. Catalyst / story: Full-market query hit: leadership base 4. Comp / narrative analogy: No explicit comp supplied; analyst must identify the closest leader/peer before sizing conviction. 5. Chart / support line: Pattern Pattern pending; price 47.05; trigger 47.9; stop/support 42.06; risk 12.19%. 5b. Measured setup validation: status invalid validated pattern none base duration 25 sessions base depth 34.644% range contraction 1.154 pivot rejection 1.672% defects: recent ranges did not contract sufficiently 6. O\u2019Neil / quality gate: CANSLIM D / 44.76; missing C, A, N, I, M. 7. Verification gaps: verified catalyst 8. Thesis alive/dead: Confirms: Breakout through trigger on expanding volume. Kills: Loss of recent structure / stop invalidation. CANSLIM/O\u2019Neil read: D / 44.76. Missing letters: C, A, N, I, M. Chart read: Pattern pending (low confidence). Trigger 47.9 Stop/invalidation 42.06. Current stance: kept in lead intake. Iris is not treating this as investable until confirmation is met and A) Execution submits/records an official working order.", "price": 47.05, "setup": "Volatility Contraction", "status": "Lead intake", "stop": 42.06, "trigger": 47.9, "what_confirms": "Breakout through trigger on expanding volume", "what_kills": "Loss of recent structure / stop invalidation", "why_now": "Full-market query hit: leadership base"}
Jul 23, 2026 12:50 UTC research Research cron update Decision: keep_in_lead_intake at score 65.0; setup Volatility Contraction; trigger 47.9 / stop 42.06. Kevin Xu lens: volume 0.8467; catalyst/story Full-market query hit: leadership base; support/risk line defined. Kevin-style verbose research: 1. Lead source: TXG entered from full_market_scan: Full-market query hit: leadership base. 2. Volume / attention: relative volume 0.8467 RS rating 0 3. Catalyst / story: Full-market query hit: leadership base 4. Comp / narrative analogy: No explicit comp supplied; analyst must identify the closest leader/peer before sizing conviction. 5. Chart / support line: Pattern Pattern pending; price 47.05; trigger 47.9; stop/support 42.06; risk 12.19%. 5b. Measured setup validation: status invalid validated pattern none base duration 25 sessions base depth 34.644% range contraction 1.154 pivot rejection 1.672% defects: recent ranges did not contract sufficiently 6. O’Neil / quality gate: CANSLIM D / 44.76; missing C, A, N, I, M. 7. Verification gaps: verified catalyst 8. Thesis alive/dead: Confirms: Breakout through trigger on expanding volume. Kills: Loss of recent structure / stop invalidation. Qullamaggie lens: Pattern pending; confirmation requires price/volume continuation, not stale list repetition. O’Neil lens: CANSLIM D / 44.76; gate 🟡 Technical setup, fundamentals incomplete; pivot 47.9; sell rule 42.06. No new blocking research gaps from this pass.
Jul 22, 2026 20:05 UTC history Historical thesis receipt {"chart_pattern": "Pattern pending", "company": "10x Genomics, Inc.", "decision": "keep_in_lead_intake", "decision_reason": "Iris kept in lead intake after immediate research. Score 65. Still needs: verified catalyst.", "narrative": "TXG entered the lead file from full_market_scan because Full-market query hit: leadership base. Kevin-style research chain: 1. Lead source: TXG entered from full_market_scan: Full-market query hit: leadership base. 2. Volume / attention: relative volume 0.8374 RS rating 0 3. Catalyst / story: Full-market query hit: leadership base 4. Comp / narrative analogy: No explicit comp supplied; analyst must identify the closest leader/peer before sizing conviction. 5. Chart / support line: Pattern Pattern pending; price 47.05; trigger 47.9; stop/support 42.06; risk 12.19%. 5b. Measured setup validation: status invalid validated pattern none base duration 25 sessions base depth 34.644% range contraction 1.154 pivot rejection 1.672% defects: recent ranges did not contract sufficiently 6. O\u2019Neil / quality gate: CANSLIM D / 44.76; missing C, A, N, I, M. 7. Verification gaps: verified catalyst 8. Thesis alive/dead: Confirms: Breakout through trigger on expanding volume. Kills: Loss of recent structure / stop invalidation. CANSLIM/O\u2019Neil read: D / 44.76. Missing letters: C, A, N, I, M. Chart read: Pattern pending (low confidence). Trigger 47.9 Stop/invalidation 42.06. Current stance: kept in lead intake. Iris is not treating this as investable until confirmation is met and A) Execution submits/records an official working order.", "price": 47.05, "setup": "Volatility Contraction", "status": "Lead intake", "stop": 42.06, "trigger": 47.9, "what_confirms": "Breakout through trigger on expanding volume", "what_kills": "Loss of recent structure / stop invalidation", "why_now": "Full-market query hit: leadership base"}
Jul 22, 2026 20:05 UTC research Research cron update Decision: keep_in_lead_intake at score 65.0; setup Volatility Contraction; trigger 47.9 / stop 42.06. Kevin Xu lens: volume 0.8374; catalyst/story Full-market query hit: leadership base; support/risk line defined. Kevin-style verbose research: 1. Lead source: TXG entered from full_market_scan: Full-market query hit: leadership base. 2. Volume / attention: relative volume 0.8374 RS rating 0 3. Catalyst / story: Full-market query hit: leadership base 4. Comp / narrative analogy: No explicit comp supplied; analyst must identify the closest leader/peer before sizing conviction. 5. Chart / support line: Pattern Pattern pending; price 47.05; trigger 47.9; stop/support 42.06; risk 12.19%. 5b. Measured setup validation: status invalid validated pattern none base duration 25 sessions base depth 34.644% range contraction 1.154 pivot rejection 1.672% defects: recent ranges did not contract sufficiently 6. O’Neil / quality gate: CANSLIM D / 44.76; missing C, A, N, I, M. 7. Verification gaps: verified catalyst 8. Thesis alive/dead: Confirms: Breakout through trigger on expanding volume. Kills: Loss of recent structure / stop invalidation. Qullamaggie lens: Pattern pending; confirmation requires price/volume continuation, not stale list repetition. O’Neil lens: CANSLIM D / 44.76; gate 🟡 Technical setup, fundamentals incomplete; pivot 47.9; sell rule 42.06. No new blocking research gaps from this pass.
Jul 22, 2026 14:00 UTC history Historical thesis receipt {"chart_pattern": "Pattern pending", "company": "10x Genomics, Inc.", "decision": "keep_in_lead_intake", "decision_reason": "Iris kept in lead intake after immediate research. Score 65. Still needs: verified catalyst.", "narrative": "TXG entered the lead file from full_market_scan because Full-market query hit: leadership base. Kevin-style research chain: 1. Lead source: TXG entered from full_market_scan: Full-market query hit: leadership base. 2. Volume / attention: relative volume 0.0886 RS rating 0 3. Catalyst / story: Full-market query hit: leadership base 4. Comp / narrative analogy: No explicit comp supplied; analyst must identify the closest leader/peer before sizing conviction. 5. Chart / support line: Pattern Pattern pending; price 46.72; trigger 47.3; stop/support 41.93; risk 11.35%. 5b. Measured setup validation: status invalid validated pattern none base duration 25 sessions base depth 33.814% range contraction 1.102 pivot rejection 0.106% defects: recent ranges did not contract sufficiently 6. O\u2019Neil / quality gate: CANSLIM D / 41.9; missing C, A, N, I, M. 7. Verification gaps: verified catalyst 8. Thesis alive/dead: Confirms: Breakout through trigger on expanding volume. Kills: Loss of recent structure / stop invalidation. CANSLIM/O\u2019Neil read: D / 41.9. Missing letters: C, A, N, I, M. Chart read: Pattern pending (low confidence). Trigger 47.3 Stop/invalidation 41.93. Current stance: kept in lead intake. Iris is not treating this as investable until confirmation is met and A) Execution submits/records an official working order.", "price": 46.72, "setup": "Volatility Contraction", "status": "Lead intake", "stop": 41.93, "trigger": 47.3, "what_confirms": "Breakout through trigger on expanding volume", "what_kills": "Loss of recent structure / stop invalidation", "why_now": "Full-market query hit: leadership base"}
Jul 22, 2026 14:00 UTC research Research cron update Decision: keep_in_lead_intake at score 65.0; setup Volatility Contraction; trigger 47.3 / stop 41.93. Kevin Xu lens: volume 0.0886; catalyst/story Full-market query hit: leadership base; support/risk line defined. Kevin-style verbose research: 1. Lead source: TXG entered from full_market_scan: Full-market query hit: leadership base. 2. Volume / attention: relative volume 0.0886 RS rating 0 3. Catalyst / story: Full-market query hit: leadership base 4. Comp / narrative analogy: No explicit comp supplied; analyst must identify the closest leader/peer before sizing conviction. 5. Chart / support line: Pattern Pattern pending; price 46.72; trigger 47.3; stop/support 41.93; risk 11.35%. 5b. Measured setup validation: status invalid validated pattern none base duration 25 sessions base depth 33.814% range contraction 1.102 pivot rejection 0.106% defects: recent ranges did not contract sufficiently 6. O’Neil / quality gate: CANSLIM D / 41.9; missing C, A, N, I, M. 7. Verification gaps: verified catalyst 8. Thesis alive/dead: Confirms: Breakout through trigger on expanding volume. Kills: Loss of recent structure / stop invalidation. Qullamaggie lens: Pattern pending; confirmation requires price/volume continuation, not stale list repetition. O’Neil lens: CANSLIM D / 41.9; gate 🟡 Technical setup, fundamentals incomplete; pivot 47.3; sell rule 41.93. No new blocking research gaps from this pass.
Jul 22, 2026 12:50 UTC history Historical thesis receipt {"chart_pattern": "Consolidation breakout", "company": "10x Genomics, Inc.", "decision": "keep_in_lead_intake", "decision_reason": "Iris kept in lead intake after immediate research. Score 68. Still needs: validated Qullamaggie setup structure.", "narrative": "TXG entered the lead file from full_market_scan because Full-market query hit: leadership base, momentum flag. Kevin-style research chain: 1. Lead source: TXG entered from full_market_scan: Full-market query hit: leadership base, momentum flag. 2. Volume / attention: relative volume 0.7199 RS rating 0 3. Catalyst / story: Full-market query hit: leadership base, momentum flag 4. Comp / narrative analogy: No explicit comp supplied; analyst must identify the closest leader/peer before sizing conviction. 5. Chart / support line: Pattern Consolidation breakout; price 47.2; trigger 47.3; stop/support 41.93; risk 11.35%. 5b. Measured setup validation: status insufficient_evidence validated pattern none base duration None sessions base depth None% range contraction 1.132 pivot rejection 0.106% defects: measured base duration/depth/tightness and pivot behavior are required 6. O\u2019Neil / quality gate: CANSLIM D / 41.9; missing C, A, N, I, M. 7. Verification gaps: validated Qullamaggie setup structure 8. Thesis alive/dead: Confirms: Breakout through trigger on expanding volume. Kills: Loss of recent structure / stop invalidation. CANSLIM/O\u2019Neil read: D / 41.9. Missing letters: C, A, N, I, M. Chart read: Consolidation breakout (medium confidence). Trigger 47.3 Stop/invalidation 41.93. Current stance: kept in lead intake. Iris is not treating this as investable until confirmation is met and A) Execution submits/records an official working order.", "price": 47.2, "setup": "Qullamaggie Breakout Flag", "status": "Lead intake", "stop": 41.93, "trigger": 47.3, "what_confirms": "Breakout through trigger on expanding volume", "what_kills": "Loss of recent structure / stop invalidation", "why_now": "Full-market query hit: leadership base, momentum flag"}
Jul 22, 2026 12:50 UTC research Research cron update Decision: keep_in_lead_intake at score 68.0; setup Qullamaggie Breakout Flag; trigger 47.3 / stop 41.93. Kevin Xu lens: volume 0.7199; catalyst/story Full-market query hit: leadership base, momentum flag; support/risk line defined. Kevin-style verbose research: 1. Lead source: TXG entered from full_market_scan: Full-market query hit: leadership base, momentum flag. 2. Volume / attention: relative volume 0.7199 RS rating 0 3. Catalyst / story: Full-market query hit: leadership base, momentum flag 4. Comp / narrative analogy: No explicit comp supplied; analyst must identify the closest leader/peer before sizing conviction. 5. Chart / support line: Pattern Consolidation breakout; price 47.2; trigger 47.3; stop/support 41.93; risk 11.35%. 5b. Measured setup validation: status insufficient_evidence validated pattern none base duration None sessions base depth None% range contraction 1.132 pivot rejection 0.106% defects: measured base duration/depth/tightness and pivot behavior are required 6. O’Neil / quality gate: CANSLIM D / 41.9; missing C, A, N, I, M. 7. Verification gaps: validated Qullamaggie setup structure 8. Thesis alive/dead: Confirms: Breakout through trigger on expanding volume. Kills: Loss of recent structure / stop invalidation. Qullamaggie lens: Consolidation breakout; confirmation requires price/volume continuation, not stale list repetition. O’Neil lens: CANSLIM D / 41.9; gate 🟡 Technical setup, fundamentals incomplete; pivot 47.3; sell rule 41.93. Still needs: validated Qullamaggie setup structure.
Jul 21, 2026 20:05 UTC history Historical thesis receipt {"chart_pattern": "Consolidation breakout", "company": "10x Genomics, Inc.", "decision": "keep_in_lead_intake", "decision_reason": "Iris kept in lead intake after immediate research. Score 68. Still needs: validated Qullamaggie setup structure.", "narrative": "TXG entered the lead file from full_market_scan because Full-market query hit: leadership base, momentum flag. Kevin-style research chain: 1. Lead source: TXG entered from full_market_scan: Full-market query hit: leadership base, momentum flag. 2. Volume / attention: relative volume 0.6846 RS rating 0 3. Catalyst / story: Full-market query hit: leadership base, momentum flag 4. Comp / narrative analogy: No explicit comp supplied; analyst must identify the closest leader/peer before sizing conviction. 5. Chart / support line: Pattern Consolidation breakout; price 47.2; trigger 47.3; stop/support 41.93; risk 11.35%. 5b. Measured setup validation: status insufficient_evidence validated pattern none base duration None sessions base depth None% range contraction 1.132 pivot rejection 0.106% defects: measured base duration/depth/tightness and pivot behavior are required 6. O\u2019Neil / quality gate: CANSLIM D / 41.9; missing C, A, N, I, M. 7. Verification gaps: validated Qullamaggie setup structure 8. Thesis alive/dead: Confirms: Breakout through trigger on expanding volume. Kills: Loss of recent structure / stop invalidation. CANSLIM/O\u2019Neil read: D / 41.9. Missing letters: C, A, N, I, M. Chart read: Consolidation breakout (medium confidence). Trigger 47.3 Stop/invalidation 41.93. Current stance: kept in lead intake. Iris is not treating this as investable until confirmation is met and A) Execution submits/records an official working order.", "price": 47.2, "setup": "Qullamaggie Breakout Flag", "status": "Lead intake", "stop": 41.93, "trigger": 47.3, "what_confirms": "Breakout through trigger on expanding volume", "what_kills": "Loss of recent structure / stop invalidation", "why_now": "Full-market query hit: leadership base, momentum flag"}